These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23886840)

  • 21. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equivalent deficits in bone mass of the vertebral body and posterior processes in women with vertebral fractures: implications regarding the pathogenesis of spinal osteoporosis.
    Seeman E; Formica C; Mosekilde L
    J Bone Miner Res; 1995 Dec; 10(12):2005-10. PubMed ID: 8619382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation.
    Wang X; Zhang H; Hu L; He J; Jiang Q; Ren L; Yu K; Fu M; Li Z; He Z; Zhu J; Wang Y; Jiang Z; Yang G
    Bone; 2024 Oct; 187():117172. PubMed ID: 38909879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoporosis and vertebral compression fractures-continued missed opportunities.
    Freedman BA; Potter BK; Nesti LJ; Giuliani JR; Hampton C; Kuklo TR
    Spine J; 2008; 8(5):756-62. PubMed ID: 18343730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging.
    Majumdar S; Genant HK; Grampp S; Newitt DC; Truong VH; Lin JC; Mathur A
    J Bone Miner Res; 1997 Jan; 12(1):111-8. PubMed ID: 9240733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Musculoskeletal phenotype in two unrelated individuals with a recurrent nonsense variant in SGMS2.
    Robinson ME; Bardai G; Veilleux LN; Glorieux FH; Rauch F
    Bone; 2020 May; 134():115261. PubMed ID: 32028018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential blindness in children of patients with hereditary bone disease.
    Kheir V; Munier FL; Aubry-Rozier B; Schorderet DF
    Osteoporos Int; 2016 Feb; 27(2):841-4. PubMed ID: 26243358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of bone mineral density after percutaneous kyphoplasty in fresh osteoporotic vertebral body fractures and adjacent vertebrae along with sagittal spine alignment.
    Korovessis P; Zacharatos S; Repantis T; Michael A; Karachalios D
    J Spinal Disord Tech; 2008 Jun; 21(4):293-8. PubMed ID: 18525491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.
    Tsugeno H; Tsugeno H; Fujita T; Goto B; Sugishita T; Hosaki Y; Ashida K; Mitsunobu F; Tanizaki Y; Shiratori Y
    Osteoporos Int; 2002 Aug; 13(8):650-6. PubMed ID: 12181624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study.
    Sornay-Rendu E; Boutroy S; Munoz F; Delmas PD
    J Bone Miner Res; 2007 Mar; 22(3):425-33. PubMed ID: 17181395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.
    Gregson CL; Poole KE; McCloskey EV; Duncan EL; Rittweger J; Fraser WD; Smith GD; Tobias JH
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2897-907. PubMed ID: 24606091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss.
    Duan Y; Turner CH; Kim BT; Seeman E
    J Bone Miner Res; 2001 Dec; 16(12):2267-75. PubMed ID: 11760841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineralization pattern of vertebral bone material following fragility fracture of the spine.
    Hofstaetter JG; Hofstaetter SG; Nawrot-Wawrzyniak K; Hiertz H; Grohs JG; Trieb K; Windhager R; Klaushofer K; Roschger P
    J Orthop Res; 2012 Jul; 30(7):1089-94. PubMed ID: 22228585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PLS3 Mutations in X-Linked Osteoporosis: Clinical and Bone Characteristics of Two Novel Mutations.
    Kannu P; Mahjoub A; Babul-Hirji R; Carter MT; Harrington J
    Horm Res Paediatr; 2017; 88(3-4):298-304. PubMed ID: 28605746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special form of osteoporosis in a 53-year-old man.
    Lampart S; Azzarello-Burri S; Henzen C; Fischli S
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.
    Ferrari SL; Deutsch S; Choudhury U; Chevalley T; Bonjour JP; Dermitzakis ET; Rizzoli R; Antonarakis SE
    Am J Hum Genet; 2004 May; 74(5):866-75. PubMed ID: 15077203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
    Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
    J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired WNT signaling and the spine-Heterozygous WNT1 mutation causes severe age-related spinal pathology.
    Mäkitie RE; Niinimäki T; Nieminen MT; Schalin-Jäntti C; Niinimäki J; Mäkitie O
    Bone; 2017 Aug; 101():3-9. PubMed ID: 28411110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High bone mass due to novel LRP5 and AMER1 mutations.
    Costantini A; Kekäläinen P; Mäkitie RE; Mäkitie O
    Eur J Med Genet; 2017 Dec; 60(12):675-679. PubMed ID: 28893644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.